Dr. Martin Rabel, a Senior Field Application Scientist at Precision NanoSystems, discusses how to accelerate the next generation of transformative medicines. Building on the success of the COVID-19 mRNA vaccine, lipid nanoparticles (LNPs) offer safe and effective ways to deliver nucleic acids enabling novel vaccines, cell and gene therapies.